{
  "id": 12311413,
  "title": "Zydus Lifesciences, MSN Launch First Generic Adempas® (Riociguat Tablets) In US",
  "url": "https://urgent.news/2026/10/06/zydus-lifesciences-msn-launch-first-generic-adempas-riociguat-tablets",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T05:23:10.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/zydus-lifesciences-msn-launch-first-generic-adempas-riociguat-tablets-in-us"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Zydus Lifesciences Limited , in partnership with MSN Laboratories Private Limited, announced on October 5, 2026, the launch of Riociguat Tablets in the United States. The tablets are available in 0.5 mg, 1 mg, 1.5 mg, 2 mg, and 2.5 mg strengths. Market Launch Zydus and MSN are the first companies to introduce a generic version of Adempas® (riociguat) in the US market . The product was…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}